El-Masry Soha M, Helmy Sally A, Helmy Soha A M, Mazyed Eman A
Department of Pharmaceutics, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt.
Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University, AL-Madinah AL-Munawarah, Kingdom of Saudi Arabia.
Drug Deliv Transl Res. 2023 Mar;13(3):795-810. doi: 10.1007/s13346-022-01239-x. Epub 2022 Oct 3.
Community and hospital pharmacists always face the challenge to prepare oral liquid extemporaneous formulations to fit the needs of a specific patient population when commercial forms or the required strength is unavailable. This study was performed to prepare a stable patient-friendly oral liquid extemporaneous formulation of bisoprolol. Eight different extemporaneous formulations were prepared using various suspending agent(s). The in vitro dissolution of all extemporaneous formulations was examined. A comprehensive accelerated stability study was carried out to evaluate the adequate beyond-use date of the most optimized extemporaneous formulation. A validated ultra-performance liquid chromatography method was used for the analysis and quantification of bisoprolol in the accelerated stability and bioavailability studies. A group of eight healthy volunteers was enrolled in a two-way cross-over experimental design to study the bioavailability of the most optimized extemporaneous formulation. The pharmacokinetic parameters of bisoprolol were estimated. Extemporaneous suspension containing 0.5% w/v xanthan gum was easily prepared with a simple, natural, safe, sugar-free excipients. It achieved the best dissolution behavior among other extemporaneous suspensions. It was an easily pourable viscous suspension with no sedimentation. At least 98% of the initial concentration of bisoprolol remained throughout the 6-month study period in the selected suspension regardless of the storage conditions. There was no perceptible change in color, odor, or taste, and no noticeable microbial growth was observed in any sample. The selected formulation was bioequivalent to the commercial tablet in terms of the rate and extent of absorption. This research may be of great help during development of appropriate extemporaneous formulation of bisoprolol fumarate. The simple preparation method could be utilized to draw up a standard operating procedure (SOP) easy to use by different types of pharmacy settings.
当没有商业制剂或所需规格的制剂时,社区和医院药剂师总是面临着配制适合特定患者群体需求的即配口服液体制剂的挑战。本研究旨在制备一种稳定的、对患者友好的比索洛尔即配口服液体制剂。使用各种助悬剂制备了八种不同的即配制剂。对所有即配制剂进行了体外溶出度检查。开展了全面的加速稳定性研究,以评估最优化即配制剂的适宜有效期。在加速稳定性和生物利用度研究中,采用经过验证的超高效液相色谱法分析和定量比索洛尔。招募了一组八名健康志愿者,采用双向交叉实验设计研究最优化即配制剂的生物利用度。估算了比索洛尔的药代动力学参数。含0.5% (w/v) 黄原胶的即配混悬剂易于用简单、天然、安全的无糖辅料制备。它在其他即配混悬剂中具有最佳的溶出行为。它是一种易于倾倒的粘性混悬剂,无沉降。在所选择的混悬剂中,无论储存条件如何,在整个6个月的研究期间,比索洛尔的初始浓度至少有98% 得以保留。颜色、气味或味道没有明显变化,任何样品中均未观察到明显的微生物生长。所选制剂在吸收速率和程度方面与市售片剂生物等效。本研究可能对富马酸比索洛尔合适的即配制剂的开发有很大帮助。这种简单的制备方法可用于制定不同类型药房易于使用的标准操作规程(SOP)。